Navigation Links
Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
Date:4/30/2008

SEATTLE, April 30 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) today announced that management will present at the following investor conferences in May.

Deutsche Bank 33rd Annual Health Care Conference

InterContinental Boston

Tuesday, May 6, 2008

8:50 a.m. ET

Bank of America Health Care Conference

Four Seasons Hotel, Las Vegas

Tuesday, May 13, 2008

11:00 a.m. ET

Rodman & Renshaw 5th Annual Global Health Care Conference

Le Meridien Beach Plaza Hotel, Monte Carlo

Monday, May 19, 2008

9:30 a.m. ET

The presentations will be audio webcast live and available for replay from Dendreon's website, http://www.dendreon.com.

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response. Active cellular immunotherapy holds promise because it may provide patients with a meaningful clinical benefit, such as survival, combined with low toxicity. The Company has its headquarters in Seattle, Washington and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit http://www.dendreon.com.


'/>"/>
SOURCE Dendreon Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Dendreon Announces Closing of Registered Direct Offering
2. Dendreon Announces $47 Million Registered Direct Offering
3. Dendreon Reports Fourth Quarter and 2007 Year End Financial Results
4. FDA Agrees to Amend Dendreons Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE
5. -Dendreon to Hold Conference Call on Thursday, March 13, 2008 at 11:00 AM ET-
6. Dendreon Publishes Manuscript on CD54 as a Surrogate Marker of Antigen Presenting Cell Activation
7. Dendreon Announces Webcast Presentation at BIO CEO & Investor Conference
8. Dendreon Promotes Dr. Mark Frohlich to Senior Vice President of Clinical Affairs and Chief Medical Officer
9. Dendreon Reports Third Quarter 2007 Financial Results
10. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
11. Dendreon Secures $130 Million Committed Equity Financing Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... DisasterTalk is a texting app which allows ... masts or other transmitters are down. The app can transmit ... the need for any Wi-Fi, and can also use a ... app has launched as a housing report finds ... risk of being affected by natural disasters. With the risk ...
(Date:7/29/2014)... The first product launch from start-up Hurley ... robotics. What sets Droidles completely apart from other stand ... them to communicate, share code with each other and ... “The invention is the system,” said Hurley Research founder ... of their own, both physically and on the internet." ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 White ... devices, and cloud based eClinical technologies, have been published ... Online. These follow a long line of white papers ... publications including Life Science Leader, Pharmaceutical Online, and OpenHealthNews. ... provided a paper by CTO Marc Desgrousilliers, 'The ...
(Date:7/28/2014)... July 28, 2014 Sapphire Energy, Inc. ... announced the appointment of biotechnology veteran James Levine ... of directors. Levine replaces Cynthia ,CJ, Warner, who is ... remain chairman of the company,s board of directors. ... mission to deliver commercial scale algae-based fuels has been ...
Breaking Biology Technology:DisasterTalk App Could Save Lives as Report Reveals 8% of US Homes at Very High Risk of Natural Disaster 2Droidles, the Social Network of Robots and Open Source Platform for the Internet of Things, Launches for Crowd Funding on IndieGoGo.com 2Clinovo White Papers Published in Summer 2014 Editions of Leading Medical Device & Pharmaceutical Publications 2Clinovo White Papers Published in Summer 2014 Editions of Leading Medical Device & Pharmaceutical Publications 3Sapphire Energy Announces New CEO James Levine 2Sapphire Energy Announces New CEO James Levine 3
... DIEGO, Dec. 9 BioMed Realty Trust, Inc. (NYSE: ... of the previously announced cash tender offer by its operating ... outstanding 4.50% Exchangeable Senior Notes due 2026 (the "Notes"). , ... 8, 2009, the scheduled expiration date of the tender offer, ...
... ... of its Brazilian regional office , ... Chicago, Ill. (Vocus) December 9, 2009 -- As part of ongoing ... Group, a world leader in the contaminated soil , sediment and groundwater ...
... , NEWTON, Mass., Dec. 8 ... announced that James N. Little, Ph.D., has informed the ... Directors effective December 31, 2009. Dr. Little has served ... appointed chairman on December 13, 2007. , (Logo: ...
Cached Biology Technology:BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes 2BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes 3Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009 2Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009 3Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009 4Microfluidics Chairman James N. Little, Ph.D., Announces Retirement from Board of Directors 2Microfluidics Chairman James N. Little, Ph.D., Announces Retirement from Board of Directors 3
(Date:7/29/2014)... researchers sometimes need to get back to basics. ... to study the impacts of the bumphead parrotfish ... at two remote locations in the central Pacific ... computer simulation, McCauley, an assistant professor in the ... his colleagues sought to understand whether the world,s ...
(Date:7/29/2014)... recover from the debilitating effects of a stroke ... knowledge of neurophysiology as well as effective therapy. ... outcomes has been the primary focus of research ... since he joined the NJIT faculty more than ... is underscored by substantial funding from sources such ...
(Date:7/29/2014)... The University of Maryland Schools of Dentistry (UM ... that they have received a five-year $10.7 million ... and Infectious Diseases (NIAID) of the National Institutes ... treatment of sexually-transmitted diseases (STDs). The grant, which ... program, represents a new direction for the research ...
Breaking Biology News(10 mins):Underwater elephants 2Underwater elephants 3Continuing the quest for better stroke therapies 2Continuing the quest for better stroke therapies 3University of Maryland Schools of Dentistry and Medicine receive NIH grant 2University of Maryland Schools of Dentistry and Medicine receive NIH grant 3University of Maryland Schools of Dentistry and Medicine receive NIH grant 4
... Water runoff from cropped farm fields can contain ... of the fertilizer and herbicide. Expanding on existing conservation ... filters socks in grassed waterways would reduce sediment flow ... reduced sediment in a non-tilled field and reduced concentrations ...
... Institute have found a way to disable a common ... forms of cancer. The researchers discovered, surprisingly, that ... protein, called MCL-1, to make a molecular tool that ... to kill the tumor cells by apoptosis, or programmed ...
... Facility (ALCF), located at the U.S. Department of Energy,s ... processor-hours of computations at a mind-boggling speed of over ... and engineers to conduct cutting-edge research in just weeks ... dedicated to enabling breakthrough science science that will ...
Cached Biology News:Compost filter socks improve runoff from croplands 2Molecular discovery suggests new strategy to fight cancer drug resistance 2Molecular discovery suggests new strategy to fight cancer drug resistance 3Over two billion hours served 2
... 5 ml of DETACHaBEAD 19 polyclonal ... CD19 (Pan B). B cells ... and released with DETACHaBEAD CD19 are ... suitable for applications such as culturing ...
This Malachite Green Phosphate Detection Kit...
5-bromo-4-chloro-3-indolyl b -D-galactopyranoside (X-Gal)...
...
Biology Products: